公司概覽
業務類別 Medical Devices
業務概覽 MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
公司地址 9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850
電話號碼 +1 301 944-1700
傳真號碼 +1 301 944-1703
公司網頁 https://www.maxcyte.com
員工數量 114
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Douglas J Swirsky Chief Financial Officer and Principal Accounting Officer 美元 460.00K 28/04/2025
Mr. David I. Sandoval Senior Vice President, General Counsel and Corporate Secretary -- 28/04/2025
Mr. Maher Masoud President, Chief Executive Officer and Director 美元 590.00K 28/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Stanley Charles Erck Independent Director 28/04/2025
Dr. Richard H. Douglas, PhD Non-Executive Chairman of the Board 28/04/2025
Ms. Cynthia Lynne Collins Director 28/04/2025
Mr. John Joseph Johnston Independent Director 28/04/2025
Dr. Yasir B. Al-Wakeel, B.M. Independent Director 28/04/2025
Mr. William Wade Brooke Independent Director 28/04/2025
Mr. Patrick J Balthrop Sr Independent Director 28/04/2025
Ms. Rekha Hemrajani, M.B.A. Independent Director 28/04/2025
Mr. Maher Masoud President, Chief Executive Officer and Director 28/04/2025
 
所屬ETF (更新日期: 07/03/2026 04:17)
代號 名稱 佔比% 持有日期
IWNiShares Russell 2000 Value ETF0.82%28/02/2026
VTWOVanguard Russell 2000 ETF0.45%31/01/2026
VHTVanguard Health Care ETF0.29%31/01/2026
IWCiShares Micro-Cap ETF0.25%28/02/2026
DFASDimensional US Small Cap ETF0.19%27/02/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.15%28/02/2026
VTWVVanguard Russell 2000 Value ETF0.07%31/01/2026
DFATDimensional US Targeted Value ETF0.05%27/02/2026
QQQSInvesco NASDAQ Future Gen 200 ETF0.04%27/02/2026
IWViShares Russell 3000 ETF0.02%28/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
UWMProShares Ultra Russell20000.01%27/02/2026
URTYProShares UltraPro Russell20000.01%27/02/2026
ITWOProShares Russell 2000 High Income ETF0.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
GUGGuggenheim Active Allocation Fund0.001%30/11/2025
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0003%31/05/2023
HDGProShares Hedge Replication0.0001%27/02/2026
AVSCAvantis US Small Cap Equity ETF<0.000001%07/02/2026
AVUSAvantis US Equity ETF<0.000001%07/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.